MARKER THERAPEUTICS INC (MRKR) Stock Analyst Earnings Estimates
NASDAQ:MRKR - Nasdaq - US57055L2060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.24M 163.83% | 9.01M 626.61% | 3.311M -63.25% | 9.781M 195.40% | 2.04M -79.14% | -100.00% | 38.731M | 24.48M -36.79% | 36.72M 50.00% | 48.96M 33.33% | 61.2M 25.00% | |
| EBITDA YoY % growth | -37.32M -31.41% | -27.16M 27.22% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -39.47M -36.62% | -29.95M 24.12% | -14.581M 51.31% | 4.311M 129.57% | -46.245M -1,172.72% | -60.184M -30.14% | -41.829M 30.50% | N/A | N/A | N/A | N/A | |
| Operating Margin | -3,183.06% | -332.41% | -440.37% | 44.08% | -2,266.90% | N/A | -108.00% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -3.86 -522.58% | -3.58 7.25% | N/A 3.13% | -0.66 80.85% | -2.36 -255.91% | -2.78 -17.61% | -1.15 58.53% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 69.00% | -0.33 -21.27% | -0.49 -96.66% | -0.63 -143.23% | -0.79 -175.99% |
| Revenue Q2Q % growth | 5.355M 406.85% | 510K -59.00% | 510K -56.37% | 510K -73.52% | 1.02M -80.95% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.055M -38.01% | -6.591M -158.58% | -9.636M -317.49% | -12.833M -434.72% | -16.988M -318.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.26 71.68% | -0.40 | 0.14 | 34.64% |
| Q2 2024 Q2Q % growth | -0.25 69.36% | -0.44 | 0.19 | 43.00% |
| Q1 2024 Q2Q % growth | -0.27 66.91% | -0.26 | -0.01 | -5.04% |
| Q4 2023 Q2Q % growth | -91.25% | -0.92 | % | |
| Q3 2023 Q2Q % growth | -14.75% | -0.92 | % | |
| Q2 2023 Q2Q % growth | 25.82% | -0.82 | % | |
| Q1 2023 Q2Q % growth | 32.00% | -0.82 | % | |
| Q4 2022 Q2Q % growth | -0.48 60.00% | -1.02 | 0.54 | 52.94% |
| Q3 2022 Q2Q % growth | -0.80 33.33% | -1.22 | 0.42 | 34.64% |
| Q2 2022 Q2Q % growth | -1.10 15.38% | -1.29 | 0.19 | 14.86% |
| Q1 2022 Q2Q % growth | -1.20 -650.00% | -1.36 | 0.16 | 11.76% |
| Q4 2021 Q2Q % growth | -1.20 -566.67% | -1.30 | 0.10 | 7.73% |
| Q3 2021 Q2Q % growth | -1.20 -650.00% | -1.30 | 0.10 | 7.73% |
| Q2 2021 Q2Q % growth | -1.30 -828.57% | -1.20 | -0.10 | -8.47% |
| Q1 2021 Q2Q % growth | -0.16 -14.29% | -0.15 | -0.01 | -8.18% |
| Q4 2020 Q2Q % growth | -0.18 -63.64% | -0.16 | -0.02 | -10.29% |
| Q3 2020 Q2Q % growth | -0.16 -33.33% | -0.15 | -0.01 | -9.44% |
| Q2 2020 Q2Q % growth | -0.14 -16.67% | -0.15 | 0.01 | 3.68% |
| Q1 2020 Q2Q % growth | -0.14 -16.67% | -0.12 | -0.02 | -20.40% |
| Q4 2019 Q2Q % growth | -0.11 | -0.13 | 0.02 | 14.41% |
| Q3 2019 Q2Q % growth | -0.12 | -0.13 | 0.01 | 10.87% |
| Q2 2019 Q2Q % growth | -0.12 | -0.13 | 0.01 | 8.09% |
| Q1 2019 Q2Q % growth | -0.12 | -0.17 | 0.05 | 30.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.926M 640.77% | 1.02M | 906K | 88.82% |
| Q2 2024 Q2Q % growth | 1.169M 53.82% | 1.169M | % | |
| Q1 2024 Q2Q % growth | 1.244M 1.14% | % | ||
| Q4 2023 Q2Q % growth | 1.057M -68.08% | 1.057M | % | |
| Q3 2023 Q2Q % growth | 260K -74.00% | 260K | % | |
| Q2 2023 Q2Q % growth | 760K -3.80% | 760K | % | |
| Q1 2023 Q2Q % growth | 1.23M 28.13% | 1.23M | % | |
| Q4 2022 Q2Q % growth | 3.31M 166.94% | 3.31M | % | |
| Q3 2022 Q2Q % growth | 1M | 272.003K | 727.997K | 267.64% |
| Q2 2022 Q2Q % growth | 790K | 680.003K | 109.997K | 16.18% |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 38.12% | 54.48% |
| Revenue | 425% | N/A | 79.6% | 117.31% |